Mimetas: New Chair of the Board
Leiden-based Mimetas, specialist in organ-on-chip-based disease models for drug discovery and development, has appointed Dhaval Patel (UCB, Belgium) as Chair of its Board of Directors.
ADVERTISEMENT
About Maren Kühr
This author has not written his bio yet.
But we are proud to say that Maren Kühr contributed 189 entries already.
Entries by Maren Kühr
Lytix Biopharma: CBO-Position new filled
Oslo-based Lytix Biopharma has a new Chief Business Officer. Stephen Worsley has started at the Norwegian immune-oncology company at the beginning of September.
New Head of Finance for Carbios
Finance Expert Pascal Bricout strengthens French Carbios as Chief of Strategy; Financial Officer and a member of the Executive Committee.
Ring exchange at Roche’s top executive level
Schwan follows Franz, Schinecker follows Schwan.
New president of Beckman Coulter Life Sciences
Beckman Coulter Life Sciences announces that Suzanne Foster has been appointed as president of the company. She succeeds Greg Milosevich, who has left the company.
Strengthening for Andera’s Life Sciences team
Jan Van den Bossche becomes the 20th partner of Andera Partners. He joined the Life Sciences team at the beginning of July to accelerate the deployment of its BioDiscovery 6 fund.
Charnwood Molecular with new CEO
Lee Patterson joins UK-based Charnwood Molecular as new CEO. After nearly 25 years at UK-based Charnwood Molecular, Prof. Steve Allin has stepping down as CEO. He will remain as an investor and Board advisor.
The silent pandemic is not silent anymore
COVID-19 is the acute pandemic, while antimicrobial resistance (AMR) is a silent, pandemic. New data makes the AMR pandemic visible, with the first global study of AMR estimating that 1.27 million people die from AMR every year, making AMR the 12th-leading cause of death globally.
Biomunex appoints new CSO
The biopharmaceutical company Biomunex Pharmaceuticals announces the appointment of Dr Simon Plyte as Chief Scientific Officer (CSO) and as a member of its scientific advisory board.
Highly pure DNA from tissue in just 50 minutes
The EchoLUTION Tissue DNA Kit from BioEcho was developed to isolate high-quality DNA in a short time, even from difficult-to-extract samples such as muscle and adipose tissue. Due to the significantly shorter lysis and reduced number of steps, the entire workflow is three to ten times faster than conventional methods that follow the bind-wash-elute principle.